Intersect ENT

Employees:
300
Market Cap:
$702.98 million
Revenue:
$78.86 million
Net Income:
$-24.71 million
NASDAQ:
XENT

Intersect ENT (NASDAQ: XENT) is a publicly traded health care equipment company based in Menlo Park, California. It manufactures drug-delivery devices used by Ear, Nose & Throat (ENT) clinicians in the treatment of sinusitis. Wikipedia

Intersect ENT
Employees:
300
Market Cap:
$702.98 million
Revenue:
$78.86 million
Net Income:
$-24.71 million
NASDAQ:
XENT

Intersect ENT (NASDAQ: XENT) is a publicly traded health care equipment company based in Menlo Park, California. It manufactures drug-delivery devices used by Ear, Nose & Throat (ENT) clinicians in the treatment of sinusitis. Wikipedia

Jun 26, 9:03 PM

We're proud of Intersect ENT's many Wonder Women of medtech, including our CEO Lisa Earnhardt, who is featured in this list by Qmed News: goo.gl/j7ZTv5

Jun 22, 11:03 PM

We are pleased to support the The American Rhinologic Society during their 6th Annual Summer Sinus Symposium in Washington, DC by sponsoring the following educational event. Sign up for the event when registering for the course. To register: http://bit.ly/2t05NN5 This is a non-CME event sponsored by Intersect ENT. It is neither sponsored by, nor endorsed by, the ARS.

May 9, 8:40 PM

Not one but two of our leadership team members are included in Becker's Hospital Review's annual list of Women in Medtech To Know. Congrats, Lisa Earnhardt and Susan Stimson! http://bit.ly/2poLh2o

Mar 7, 7:10 PM

Heres the Manufacturing team behind PROPEL Contour, our newest steroid releasing implant. Important Safety info: bit.ly/2mqRnxZ

3 jobs at Intersect ENT

Jobs in